Somewhere in industry, a chatbot just got blamed for a warning letter
FDA cited a firm that relied on AI for GMP documentation and then said it did not know process validation was required, because the AI never mentioned it.
FDA cited a firm that reportedly relied on AI for GMP-related documentation and then said it did not know process validation was required, because the AI never mentioned it.
That is not automation. That is delegation with vibes.
Let us all remember:
- AI can draft.
- AI can suggest.
- AI can summarise.
And:
- AI cannot know your product.
- AI cannot own your quality system.
- AI cannot replace competent review by authorised personnel.
- AI cannot save you when the investigator says, “Walk me through your rationale.”
Imagine explaining: “We thought the robot would bring it up.”
The takeaway is not “do not use AI”. The takeaway is do not use AI like an unpaid intern and then act surprised when FDA expects adult supervision.
Human oversight is still required. Quality Unit review is still required. Process validation is still required.
And yes — reading the regulations yourself is still highly recommended.
Adapted from a post first published on LinkedIn.